Cronos Group Inc. (CRON.TO)

CAD 2.44

(-0.41%)

Long Term Debt Summary of Cronos Group Inc.

Cronos Group Inc.'s latest annual long term debt in 2023 was 1.55 Million USD , down -38.77% from previous year.
Cronos Group Inc.'s latest quarterly long term debt in 2024 Q2 was 1.06 Million USD , down 0.0% from previous quarter.
Cronos Group Inc. reported annual long term debt of 2.54 Million USD in 2022, down -64.12% from previous year.
Cronos Group Inc. reported annual long term debt of 7.09 Million USD in 2021, down -16.45% from previous year.
Cronos Group Inc. reported quarterly long term debt of 1.06 Million USD for 2024 Q2, down 0.0% from previous quarter.
Cronos Group Inc. reported quarterly long term debt of 1.75 Million USD for 2023 Q3, down -14.44% from previous quarter.

Annual Long Term Debt Chart of Cronos Group Inc. (2023 - 2013)

Historical Annual Long Term Debt of Cronos Group Inc. (2023 - 2013)

Year	Long Term Debt	Long Term Debt Growth
2023	1.55 Million USD	-38.77%
2022	2.54 Million USD	-64.12%
2021	7.09 Million USD	-16.45%
2020	8.49 Million USD	27.13%
2019	6.68 Million CAD	0.0%
2018	- CAD	-100.0%
2017	4.26 Million CAD	0.0%
2016	- CAD	-100.0%
2015	360.31 Thousand CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	1.3 Million USD	0.0%
2024 Q2	1.06 Million USD	0.0%
2023 Q3	1.75 Million USD	-14.44%
2023 FY	1.55 Million USD	-38.77%
2023 Q1	2.29 Million USD	-9.82%
2023 Q2	2.05 Million USD	-10.71%
2023 Q4	1.55 Million USD	-11.12%
2022 Q3	4.99 Million USD	-24.94%
2022 FY	2.54 Million USD	-64.12%
2022 Q1	7.09 Million USD	-0.01%
2022 Q4	2.54 Million USD	-49.02%
2022 Q2	6.65 Million USD	-6.22%
2021 Q2	6.33 Million USD	-23.06%
2021 FY	7.09 Million USD	-16.45%
2021 Q1	8.23 Million USD	-3.07%
2021 Q4	7.09 Million USD	-3.38%
2021 Q3	7.34 Million USD	15.95%
2020 Q2	8.95 Million USD	-5.25%
2020 Q3	8.61 Million USD	-3.86%
2020 Q4	8.49 Million USD	-1.39%
2020 FY	8.49 Million USD	27.13%
2020 Q1	9.45 Million USD	41.53%
2019 FY	6.68 Million CAD	0.0%
2019 Q4	6.68 Million CAD	14.19%
2019 Q3	5.84 Million CAD	147.01%
2019 Q2	2.36 Million CAD	73.07%
2019 Q1	1.36 Million CAD	1472.8%
2018 Q4	87 Thousand CAD	0.0%
2018 Q1	4.3 Million CAD	0.79%
2018 FY	- CAD	-100.0%
2018 Q3	- CAD	-100.0%
2018 Q2	4.23 Million CAD	-1.63%
2017 Q3	4.04 Million CAD	0.0%
2017 Q2	- CAD	0.0%
2017 FY	4.26 Million CAD	0.0%
2017 Q1	- CAD	0.0%
2017 Q4	4.26 Million CAD	5.43%
2016 Q2	- CAD	-100.0%
2016 Q4	- CAD	0.0%
2016 Q3	- CAD	0.0%
2016 FY	- CAD	-100.0%
2016 Q1	385.19 Thousand CAD	6.91%
2015 Q3	372.43 Thousand CAD	-7.54%
2015 Q1	394.38 Thousand CAD	0.0%
2015 FY	360.31 Thousand CAD	0.0%
2015 Q4	360.31 Thousand CAD	-3.26%
2015 Q2	402.8 Thousand CAD	2.13%
2014 Q3	- CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q2	- CAD	0.0%
2013 FY	- CAD	0.0%

Peer Long Term Debt Comparison of Cronos Group Inc.

Name	Long Term Debt	Long Term Debt Difference
Aurora Cannabis Inc.	47.57 Million CAD	96.723%
Avicanna Inc.	95.36 Thousand CAD	-1534.823%
Avant Brands Inc.	1.74 Million CAD	10.454%
Cardiol Therapeutics Inc.	158.53 Thousand CAD	-883.398%
Crescita Therapeutics Inc.	815 Thousand CAD	-91.288%
Knight Therapeutics Inc.	44.01 Million CAD	96.458%
MediPharm Labs Corp.	69 Thousand CAD	-2159.42%
OrganiGram Holdings Inc.	79 Thousand CAD	-1873.418%
Canopy Growth Corporation	493.29 Million CAD	99.684%
Willow Biosciences Inc.	594 Thousand CAD	-162.458%
Auxly Cannabis Group Inc.	81.38 Million CAD	98.084%